Efficacy of modified bevacizumab-XELOX therapy in Japanese patients with stage IV recurrent or non-resectable colorectal cancer

Daiki Yokoyama, Masaya Mukai, Shuji Uda, Kyouko Kishima, Takuya Koike, Sayuri Hasegawa, Hideki Izumi, Souichirou Yamamoto, Takayuki Tajima, Eiji Nomura, Hiroyasu Makuuchi